Table 2 Descriptive statistics of outcome measures at baseline
|  | Control (N = 37) | Experimental (N = 35) | Total |  | ||||
|---|---|---|---|---|---|---|---|---|
Mean | SD | Mean | SD | Mean | SD | P | ||
State Hope Scale | ||||||||
 Total | 29.2 | 8.45 | 29.8 | 9.47 | 29.51 | 8.91 | 0.767 | |
 Pathway | 13.7 | 4.91 | 14.3 | 5.48 | 13.99 | 5.17 | 0.601 | |
 Agency | 15.5 | 4.85 | 15.5 | 5.07 | 15.52 | 4.92 | 0.991 | |
Decisional Conflict Scale | ||||||||
 Total | 49.6 | 18.42 | 44.0 | 20.60 | 46.9 | 19.58 | 0.227 | |
 Being informed | 62.6 | 30.97 | 56.4 | 31.77 | 59.6 | 31.30 | 0.406 | |
 Values clarity | 65.5 | 32.22 | 52.4 | 29.12 | 59.1 | 31.25 | 0.074 | |
 Support | 32.7 | 22.51 | 36.2 | 17.96 | 34.4 | 20.36 | 0.466 | |
 Uncertainty | 55.4 | 26.15 | 49.3 | 31.20 | 52.4 | 28.68 | 0.369 | |
 Effective decision | 36.5 | 24.09 | 30.2 | 18.28 | 33.4 | 21.55 | 0.217 | |
Kidney Disease Quality of Life (KDQOL-36) | ||||||||
 Short form health survey (SF-12) |  |  |  |  |  |  |  | |
 KDQOL-36 (PCS)a | 64.8 | 23.32 | 62.9 | 26.74 | 63.9 | 24.89 | 0.738 | |
 KDQOL-36 (MCS)b | 74.3 | 23.90 | 67.9 | 24.98 | 71.2 | 24.48 | 0.266 | |
 Burden of kidney disease | 54.2 | 31.39 | 49.5 | 26.79 | 51.9 | 29.14 | 0.492 | |
 Symptoms and problems | 90.4 | 15.24 | 84.4 | 15.54 | 87.5 | 15.57 | 0.106 | |
 Effects of kidney disease | 87.8 | 15.73 | 85.3 | 15.00 | 86.6 | 15.32 | 0.485 | |